A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

Objective: The objective was to evaluate the contraceptive effectiveness, safety, and acceptability of a novel vaginal pH regulator over seven cycles of use. Study design: A single-arm, open-label, phase 3 study was conducted across 112 sites in the United States in sexually active 18–35-year-old wo...

Full description

Bibliographic Details
Main Authors: Michael A. Thomas, B. Todd Chappell, Bassem Maximos, Kelly R. Culwell, Clint Dart, Brandon Howard
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Contraception: X
Subjects:
Contraception
Nonhormonal
Vaginal gel
Phase 3 trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2590151620300149

Similar Items

Similar Items